NasdaqGM · Biotechnology

Galapagos NV (GLPG)

Stock, pipeline and biotech catalyst intelligence

$27.73Price unavailableCached market snapshot

Market cap$1.86B

Cash$2.98B

Quarterly burn$82.8M

Pipeline assets14

Short float3.1%

Clinical portfolio

Galapagos NV Drug Pipeline

Showing 1 of 14

Asset	Indication	Stage	Milestone	Signals ?
GLPG5301 BCMA CAR-T	Multiple myeloma, High Refractory Multiple Myeloma	Failed	TBA	—

Continue with BioPharma ProUnlock 13 additional programs and complete development details.

Upcoming milestones

1 currently tracked

TBA

Failed

Multiple myeloma, High Refractory Multiple Myeloma

Discontinued

Event details

Company profile

Galapagos NV is a biotechnology company in the healthcare sector.

Company profile compiled from available company records. Catalyst dates can change and should be confirmed against the linked primary source.

Page updated Aug 23, 2026 · Yahoo quotes cached for one minute; reference data may be used when a live field is unavailable.